GBM91 GBM Model

Patient-derived xenograft GBM91 is a groundbreaking tool revolutionizing Brain Cancer drug development. It enables personalized testing of potential therapies, a game-changer in treatment strategies. GBM91 PDX meticulously replicates patient tumor responses, allowing researchers to predict treatment outcomes and potential toxicity accurately. By tailoring therapies to individual patient needs, GBM91 PDX paves the way for safer and more effective Brain Cancer treatments, marking a significant advancement in preclinical drug discovery.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM91
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes

GBM91 Survival

Survival of orthotopic intracranial implanted  GBM91 in Nu/Nu mice  (n=5)